Single Use Bioreactors Market Size to Reach USD 12.24 Billion in 2032

KOLKATA, India - July 10, 2025 - PRLog -- Growing usage of bioreactors for medium preparation, cell culture, process development, optimization, and microbial processes is driving market revenue growth. Traditional bioreactors rely significantly on Cleaning-in-Place (CIP) and Sterilization-in-Place (SIP) operations, which may be both time-consuming and energy-intensive.

Read More : https://navistratanalytics.com/report_store/single-use-bioreactors-market/

Segment and Regional market overview and growth Insights:

The Contract Manufacturing Organization (CMO) segment contributed a significant revenue share in 2024. The biopharmaceutical industry has grown significantly, leading to the emergence of the contract development and manufacturing organization (CDMO), with monoclonal antibody production platforms.

Asia Pacific is expected to register the fastest revenue growth, reaching 19.3% by 2032. Surge in demand for bio-pharmaceutical manufacturing is accelerating revenue growth in this region.

Competitive Landscape and Key Competitors:

• Thermo Fisher Scientific Inc.
• Cytiva
• Merck KGaA
• WuXi Biologics
• Sartorius AG
• Eppendorf SE